TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Health & Fitness

    Emergency Medical Minute

    Our near daily podcasts move quickly to reflect current events, are inspired by real patient care, and speak to the true nature of what it’s like to work in the Emergency Room or Pre-Hospital Setting. Each medical minute is recorded in a real emergency department, by the emergency physician or clinical pharmacist on duty – the ER is our studio and everything is live.

    Advertise

    Copyright: © Copyright Emergency Medical Minute 2019

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Podcast 914: Neuroleptic Malignant Syndrome (NMS) Jul 29, 2024
    Show notes

    Contributor: Taylor Lynch, MD

    Educational Pearls:

    What is NMS?

    • Neuroleptic Malignant Syndrome

    • Caused by anti-dopamine medication or rapid withdrawal of pro-dopamenergic medications

    • Mechanism is poorly understood

    • Life threatening

    What medications can cause it?

    • Typical antipsychotics

      • Haloperidol, chlorpromazine, prochlorperazine, fluphenazine, trifluoperazine

    • Atypical antipsychotics

      • Less risk

      • Risperidone, clozapine, quetiapine, olanzapine, aripiprazole, ziprasidone

    • Anti-emetic agents with anti dopamine activity

      • Metoclopramide, promethazine, haloperidol

      • Not ondansetron

    • Abrupt withdrawal of levodopa

    How does it present?

    • Slowly over 1-3 days (unlike serotonin syndrome which has a more acute onset)

    • Altered mental status, 82% of patients, typically agitated delirium with confusion

    • Peripheral muscle rigidity and decreased reflexes. AKA lead pipe rigidity. (As opposed to clonus and hyperreflexia in serotonin syndrome)

    • Hyperthermia (>38C seen in 87% of patients)

    • Can also have tachycardia, labile blood pressures, tachypnea, and tremor

    How is it diagnosed?

    • Clinical diagnosis, focus on the timing of symptoms

    • No confirmatory lab test but can see possible elevated CK levels and WBC of 10-40k with a left shift

    What else might be on the differential?

    • Sepsis

    • CNS infections

    • Heat stroke

    • Agitated delirium

    • Status eptilepticus

    • Drug induced extrapyramidal symptoms

    • Serotonin syndrome

    • Malignant hyperthermia

    What is the treatment?

    • Start with ABC's

    • Stop all anti-dopaminergic meds and restart pro-dopamine meds if recently stopped

    • Maintain urine output with IV fluids if needed to avoid rhabdomyolysis

    • Active or passive cooling if needed

    • Benzodiazapines, such as lorazepam 1-2 mg IV q 4hrs

    What are active medical therapies?

    • Controversial treatments

    • Bromocriptine, dopamine agonist

    • Dantrolene, classically used for malignant hyperthermia

    • Amantadine, increases dopamine release

    • Use as a last resort

    Dispo?

    • Mortality is around 10% if not recognized and treated

    • Most patients recover in 2-14 days

    • Must wait 2 weeks before restarting any medications

    References

    • Oruch, R., Pryme, I. F., Engelsen, B. A., & Lund, A. (2017). Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatric disease and treatment, 13, 161–175. https://doi.org/10.2147/NDT.S118438

    • Tormoehlen, L. M., & Rusyniak, D. E. (2018). Neuroleptic malignant syndrome and serotonin syndrome. Handbook of clinical neurology, 157, 663–675. https://doi.org/10.1016/B978-0-444-64074-1.00039-2

    • Velamoor, V. R., Norman, R. M., Caroff, S. N., Mann, S. C., Sullivan, K. A., & Antelo, R. E. (1994). Progression of symptoms in neuroleptic malignant syndrome. The Journal of nervous and mental disease, 182(3), 168–173. https://doi.org/10.1097/00005053-199403000-00007

    • Ware, M. R., Feller, D. B., & Hall, K. L. (2018). Neuroleptic Malignant Syndrome: Diagnosis and Management. The primary care companion for CNS disorders, 20(1), 17r02185. https://doi.org/10.4088/PCC.17r02185

    Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSIII


    Episode 913: Vasopressors after ROSC Jul 23, 2024
    Show notes

    Contributor: Travis Barlock MD

    Educational Pearls:

    • Recent study assessed outcomes after ROSC with epinephrine vs. norepinephrine

      • Observational multicenter study from 2011-2018

      • 285 patients received epineprhine and 481 received norepinephrine

    • Epinephrine was associated with an increase in all-cause mortality (primary outcome)

      • Odds ratio 2.6; 95%CI 1.4-4.7; P = 0.002

      • Higher cardiovascular mortality (secondary outcome)

      • Higher proportion of unfavorable neurological outcome (secondary outcome)

    • Norepinephrine is the vasopressor of choice in post-cardiac arrest care

    References

    1. Bougouin W, Slimani K, Renaudier M, et al. Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med. 2022;48(3):300-310. doi:10.1007/s00134-021-06608-7

    Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit


    Podcast 912: Narcan (Naloxone) Jul 15, 2024
    Show notes

    Contributor: Taylor Lynch, MD

    Educational Pearls:

    Opioid Epidemic- quick facts

    • Drug overdoses, primarily driven by opioids, have become the leading cause of accidental death in the U.S. for individuals aged 18-45.

    • In 2021, opioids were involved in nearly 75% of all drug overdose deaths

    • The rise of synthetic opioids like fentanyl, which is much more potent than heroin or prescription opioids, has played a major role in the increase in overdose deaths

    What is Narcan AKA Naloxone?

    • Competitive opioid antagonist. It sits on the receptor but doesn't activate it.

    When do we give Narcan?

    • Respiratory rate less than 8-10 breaths per minute

    Should you check the pupils?

    • An opioid overdose classically presents with pinpoint pupils BUT…

    • Hypercapnia from bradypnea can normalize the pupils

    • Taking other drugs at the same time like cocaine or meth can counteract the pupillary effects

    • Basilar stroke could also cause small pupils, so don't anchor on an opioid overdose

    How does Narcan affect the body?

    • Relatively safe even if the patient is not experiencing an opioid overdose. So when in doubt, give the Narcan.

    • What if the patient is opioid naive and overdosing?

      • Use a large dose given that this patient is unlikely to withdraw

      • 0.4-2 mg every 3-5 minutes

    • What if the patient is a chronic opioid user

      • Use a smaller dose such as 0.04-0.4 mg to avoid precipitated withdrawal

    How fast does Narcan work?

    • Given intravenously (IV), onset is 1-2 min

    • Given intranasal (IN), onset is 3-4 min

    • Given intramuscularly (IM), onset is ~6 min

    • Duration of action is 60 mins, with a range of 20-90 minutes

    How does that compare to the duration of action of common opioids?

    • Heroine lasts 60 min

    • Fentanyl lasts 30-60 min, depending on route

    • Carfentanyl lasts ~5 hrs

    • Methadone lasts 12-24 hrs

    • So we really need to be conscious about redosing

    How do you monitor someone treated with Narcan?

    • Pay close attention to the end-tidal CO2 to ensure that are ventilating appropriately

    • Be cautious with giving O2 as it might mask hypoventilation

    • Watch the respiratory rate

    • Give Narcan as needed

    • Observe for at least 2-4 hours after the last Narcan dose

    • Larger the dose, longer the observation period

    Who gets a drip?

    • If they have gotten ~3 doses, time to start the drip

    • Start at 2/3rds last effective wake-up dose

    Complications

    • Flash pulm edema

      • 0.2-3.6% complication rate

      • Might be from the catecholamine surge from abrupt wake-up

      • Might also be from large inspiratory effort against a partially closed glottis which creates too much negative pressure

      • Treat with BIPAP if awake and intubation if not awake

    Should you give Narcan in cardiac arrest?

    • Short answer no. During ACLS you take over breathing for the patient and that is pretty much the only way that Narcan can help

    • Just focus on high quality CPR

    References

    • https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20prescription,of%20deaths%20declined%20to%2014%2C716.

    • Elkattawy, S., Alyacoub, R., Ejikeme, C., Noori, M. A. M., & Remolina, C. (2021). Naloxone induced pulmonary edema. Journal of community hospital internal medicine perspectives, 11(1), 139–142. https://doi.org/10.1080/20009666.2020.1854417

    • van Lemmen, M., Florian, J., Li, Z., van Velzen, M., van Dorp, E., Niesters, M., Sarton, E., Olofsen, E., van der Schrier, R., Strauss, D. G., & Dahan, A. (2023). Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest. Anesthesiology, 139(3), 342–353. https://doi.org/10.1097/ALN.0000000000004622

    • Yousefifard, M., Vazirizadeh-Mahabadi, M. H., Neishaboori, A. M., Alavi, S. N. R., Amiri, M., Baratloo, A., & Saberian, P. (2019). Intranasal versus Intramuscular/Intravenous Naloxone for Pre-hospital Opioid Overdose: A Systematic Review and Meta-analysis. Advanced journal of emergency medicine, 4(2), e27. https://doi.org/10.22114/ajem.v0i0.279

    Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSII


    Episode 911: Anticholinergic Toxicity Jul 08, 2024
    Show notes

    Contributor: Taylor Lynch MD

    Educational Pearls:

    • Anticholinergics are found in many medications, including over-the-counter remedies

    • Medications include:

      • Diphenhydramine

      • Tricyclic antidepressants like amitriptyline

      • Atropine

      • Antipsychotics like olanzapine

      • Antispasmodics - dicyclomine

      • Jimsonweed

      • Muscaria mushrooms

    • Mechanism of action involves competitive antagonism of the muscarinic receptor

    • Symptomatic presentation is easily remembered via the mnemonic:

      • Dry as a bone - anhidrosis due to cholinergic antagonism at sweat glands

      • Red as a beet - cutaneous vasodilation leads to skin flushing

      • Hot as a hare - anhidrotic hyperthermia

      • Blind as a bat - pupillary dilation and ineffective accommodation

      • Mad as a hatter - anxiety, agitation, dysarthria, hallucinations, and others

    • Clinical management

      • ABCs

      • Benzodiazepines for supportive care, agitation, and seizures

      • Sodium bicarbonate for TCA toxicity due to widened QRS

      • Activated charcoal if patient present

      • Temperature monitoring

      • Contact poison control with questions

    • Physostigmine controversy

      • Physostigmine is a reversible cholinesterase inhibitor that can cross the blood-brain barrier so in theory it would be a useful antidote BUT…

      • There is a black box warning for asystole and seizures when physostigmine is used this way

      • Therefore it is contraindicated in TCA overdoses

      • However, it is still indicated in certain anticholinergic overdoses with delirium

    • Disposition

      • Admission criteria include: symptoms >6 hours, CNS findings, QRS prolongation, hyperthermia, and rhabdomyolysis

      • ICU admission criteria include: delirium, dysrhythmias, seizures, coma, or requirement for physostigmine drip

    References

    1. Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review. Clin Toxicol (Phila). 2018;56(2):101-107. doi:10.1080/15563650.2017.1342828

    2. Nguyen TT, Armengol C, Wilhoite G, Cumpston KL, Wills BK. Adverse events from physostigmine: An observational study. Am J Emerg Med. 2018;36(1):141-142. doi:10.1016/j.ajem.2017.07.006

    3. Scharman E, Erdman A, Wax P, et al. Diphenhydramine and dimenhydrinate poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2006;44(3):205-223. doi:10.1080/15563650600585920

    4. Shervette RE 3rd, Schydlower M, Lampe RM, Fearnow RG. Jimson "loco" weed abuse in adolescents. Pediatrics. 1979;63(4):520-523.

    5. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2007;45(3):203-233. doi:10.1080/15563650701226192

    Summarized by Jorge Chalit, OMSIII | Edited by Jorge Chalit


    Episode 910: Cellulitis Recovery Timeline Jul 02, 2024
    Show notes

    Contributor: Aaron Lessen, MD

    Educational Pearls:

    How fast does cellulitis recover?

    • A recent prospective cohort study took a look at this question.

    • The study included 300 adults with cellulitis (excluding those with peri-orbital cellulitis or abscesses) in two emergency departments in Queensland, Australia.

    • They collected data from initial and follow-up surveys at 3, 7, and 14 days, and compared clinician and patient assessments at day 14.

    • Improvement was fastest between day 0 and day 3, with gradual progress thereafter.

    • At day 14, many still had skin redness and swelling, though warmth had often resolved. Clinicians reported higher cure rates than patients (85.8% vs. 52.8%).

    • Conclusion:

      • Cellulitis symptoms improve quickly at first but continue to linger for many patients.

      • Patients and doctors often have different views on when cellulitis is fully cured.

    How should we counsel patients?

    • Even on antibiotics, the margins of the cellulitis may continue to spread a small amount.

    • Skin warmth should be the first symptom to go away.

    • It takes time to get better. Only about 50% of patients believed their cellulitis was cured at 2 weeks.

    References

    1. Nightingale, R. S., Etheridge, N., Sweeny, A. L., Smyth, G., Dace, W., Pellatt, R. A. F., Snelling, P. J., Yadav, K., & Keijzers, G. (2024). Cellulitis in the Emergency Department: A prospective cohort study with patient-centred follow-up. Emergency medicine Australasia : EMA, 10.1111/1742-6723.14401. Advance online publication. https://doi.org/10.1111/1742-6723.14401

    Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSIII


    Episode 909: Prehospital Blood Pressure Management in Suspected Stroke Jun 24, 2024
    Show notes

    Contributor: Aaron Lessen MD

    Educational Pearls:

    • A recent study assessed EMS treatment of high blood pressure in the field

    • 2404 patients randomized to prehospital treatment (1205) vs. usual care (1199)

      • Included patients with prehospital BP greater than 150 mm Hg

      • The treatment arm's BP goal was 130-140 mm Hg

      • The primary efficacy outcome was functional status 90 days out

    • Stroke was confirmed by imaging upon hospital arrival

      • On arrival, the mean SBP of the treatment arm was 159 mm Hg compared with 170 mm Hg in the usual care group

    • No significant difference in functional outcomes between the treatment group and the usual care group (Common Odds Ratio of 1.00, 95% CI = 0.87-1.15)

    • Post-imaging analysis revealed 46.5% of the undifferentiated patients had a hemorrhagic stroke

      • Prehospital reduction in BP did reduce the odds of poor functional outcome in hemorrhagic stroke patients alone (Common Odds Ratio 0.75, 95% CI 0.60-0.92)

      • Those with ischemic stroke had increased odds of poor functional outcome (Common Odds Ratio 1.30, 95% CI 1.06-1.60)

    • Bottom line: it is challenging to identify the stroke type in the prehospital setting and therefore not necessarily helpful to treat the blood pressure

    References

    1. Ren X, Zhang C, Xu P, et al. Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke. New England Journal of Medicine. 2024;390(20):1862-1872. doi:10.1056/NEJMoa2314741

    Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit


    Episode 908: Sympathomimetic Drugs Jun 17, 2024
    Show notes

    Contributor: Taylor Lynch MD

    Educational Pearls:

    • Overview:
      • Sympathomimetic drugs mimic the fight or flight response, affecting monoamines such as dopamine, norepinephrine, and epinephrine
      • Limited therapeutic use, often abused.
    • Types:
      • Amphetamines: Methamphetamine, Adderall, Ritalin, Vyvanse
      • MDMA (Ecstasy)
      • Cocaine (Both hydrochloride salt & free based crack cocaine)
      • Theophylline (Asthma treatment)
      • Ephedrine (For low blood pressure)
      • BZP, Oxymetazoline (Afrin), Pseudoephedrine (Sudafed)
      • MAO Inhibitors (treatment-resistant depression)
    • Mechanisms:
      • Act on adrenergic and dopaminergic receptors.
      • Cocaine blocks dopamine and serotonin reuptake.
      • Methamphetamines increase stimulatory neurotransmitter release
      • MAO Inhibitors prevent neurotransmitter breakdown.
    • Symptoms:
      • Agitation, tachycardia, hypertension, hyperactive bowel sounds, diuresis, hyperthermia.
      • Severe cases: Angina, seizures, cardiovascular collapse.
    • Diagnosis:
      • Clinical examination and history.
      • Differentiate from anticholinergic toxidrome by diaphoresis and hyperactive bowel sounds.
      • Tests: EKG, cardiac biomarkers, chest X-ray, blood gas, BMP, CK, coagulation studies, U-tox screen.
    • Treatment:
      • Stabilize ABCs, IV hydration, temperature monitoring, benzodiazepines.
      • Avoid beta-blockers due to unopposed alpha agonism.
      • Whole bowel irrigation for body packers; surgical removal if packets rupture.
      • IV hydration for high CK levels.
      • Observation period often necessary.
    • Recap:
      • Mimic sympathetic nervous system.
      • Key symptoms: Diaphoresis, hyperactive bowel sounds.
      • Treatment: Supportive care, benzodiazepines.
      • Use poison control as a resource.

    References:

    1. Costa VM, Grazziotin Rossato Grando L, Milandri E, Nardi J, Teixeira P, Mladěnka P, Remião F. Natural Sympathomimetic Drugs: From Pharmacology to Toxicology. Biomolecules. 2022;12(12):1793. doi:10.3390/biom12121793

    2. Kolecki P. Sympathomimetic Toxicity From Emergency Medicine. Medscape. Updated March 11, 2024. https://emedicine.medscape.com/article/818583-overview

    3. Williams RH, Erickson T, Broussard LA. Evaluating Sympathomimetic Intoxication in an Emergency Setting. Lab Med. 2000;31(9):497-508. https://doi.org/10.1309/WVX1-6FPV-E2LC-B6YG

    Summarized by Steven Fujaros | Edited by Jorge Chalit, OMSIII


    Episode 907: Wide-Complex Tachycardia Jun 12, 2024
    Show notes

    Contributor: Travis Barlock MD

    Educational Pearls:

    • Wide-complex tachycardia is defined as a heart rate > 100 BPM with a QRS width > 120 milliseconds

    • Wide-complex tachycardia of supraventricular origin is known as SVT with aberrancy

      • Aberrancy is due to bundle branch blocks

      • Mostly benign

      • Treated with adenosine or diltiazem

    • Wide-complex tachycardia of ventricular origin is also known as VTach

      • Originates from ventricular myocytes, which are poor inherent pacemakers

      • Dangerous rhythm that can lead to death

      • Treated with amiodarone or lidocaine

    • 80% of wide-complex tachycardias are VTach

      • 90% likelihood for patients with a history of coronary artery disease

    • In assessing a wide-complex tachycardia, it is best to treat it as a presumed ventricular tachycardia

      • Treating SVT with amiodarone or lidocaine does no harm

      • However, treating VTach with adenosine or diltiazem may worsen the condition

    References

    1. Littmann L, Olson EG, Gibbs MA. Initial evaluation and management of wide-complex tachycardia: A simplified and practical approach. Am J Emerg Med. 2019;37(7):1340-1345. doi:https://doi.org/10.1016/j.ajem.2019.04.027

    2. Viskin S, Chorin E, Viskin D, Hochstadt A, Schwartz AL, Rosso R. Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy. Circulation. 2021;144(10):823-839. doi:10.1161/CIRCULATIONAHA.121.055783

    3. Williams SE, O'Neill M, Kotadia ID. Supraventricular tachycardia: An overview of diagnosis and management. Clin Med J R Coll Physicians London. 2020;20(1):43-47. doi:10.7861/clinmed.cme.20.1.3

    Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit


    Episode 906: Case Study of Hypernatremia Jun 03, 2024
    Show notes

    Contributor: Aaron Lessen MD

    Educational Pearls:

    The case:

    • A gentleman came in from a nursing home with symptoms concerning for sepsis. He was hypotensive, hypoxic, febrile, and mentally altered.

    • His past medical history included previous strokes which had left him with deficits for which he required a feeding tube.

    • Initial workup included some point of care labs which revealed a sodium of 165 mEq/L (normal range 135-145)

    Hypernatremia

    • What causes it?

      • Dehydration, from insufficient fluid intake. This might happen in individuals who cannot drink water independently, such as infants, elderly, or disabled people, as was the case for this patient.

      • Other causes of dehydration/hypernatremia include excessive sweating; diabetes insipidus; diuretic use; kidney dysfunction; and severe burns which can lead to fluid loss through the damaged skin.

    • How do you correct it?

      • Need to correct slowly, not more than 10 to 12 meq/L in 24 hours

      • Can do normal saline (0.9%) or half saline (0.45%) and D5, at 150-200 mL per hour.

      • Check the sodium frequently (every 2-3 hours)

      • Will likely need ICU-level monitoring

    • What happens if you correct it too quickly?

      • Cerebral edema

      • Seizures

    Bonus fact: Correction of hyponatremia too quickly causes osmotic demyelination syndrome (ODS).

    References

    1. Chauhan, K., Pattharanitima, P., Patel, N., Duffy, A., Saha, A., Chaudhary, K., Debnath, N., Van Vleck, T., Chan, L., Nadkarni, G. N., & Coca, S. G. (2019). Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients. Clinical journal of the American Society of Nephrology : CJASN, 14(5), 656–663. https://doi.org/10.2215/CJN.10640918

    2. Lindner, G., & Funk, G. C. (2013). Hypernatremia in critically ill patients. Journal of critical care, 28(2), 216.e11–216.e2.16E20. https://doi.org/10.1016/j.jcrc.2012.05.001

    3. Muhsin, S. A., & Mount, D. B. (2016). Diagnosis and treatment of hypernatremia. Best practice & research. Clinical endocrinology & metabolism, 30(2), 189–203. https://doi.org/10.1016/j.beem.2016.02.014

    Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSIII


    Episode 905: Oseltamivir (Tamiflu) for Influenza May 27, 2024
    Show notes

    Contributor: Aaron Lessem MD

    Educational Pearls:

    • Oseltamivir (Tamiflu) is an antiviral medication used commonly to treat influenza

    • Trials show that the medication reduces the duration of illness by less than 1 day (~16 hours in one systematic review)

      • Benefit only occurs if taken within 48 hours of symptom onset

      • Must be taken for 5 days

    • A 2024 meta-analysis reviewed 15 randomized-controlled trials for the risk of hospitalization

      • No reduction in hospitalizations with oseltamivir in patients over the age of 12

      • No difference in high-risk patients over the age of 65 or those with comorbidities

        • The authors note that the confidence interval in these populations is wide, indicating a need for subsequent studies in high-risk populations

    • Oseltamivir is associated with adverse effects including nausea, vomiting, and neurologic symptoms

      • The risk of adverse effects may outweigh the benefits of a small reduction in the duration of illness

    References

    1. Hanula R, Bortolussi-Courval É, Mendel A, Ward BJ, Lee TC, McDonald EG. Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients with Influenza: A Systematic Review and Meta-Analysis. JAMA Intern Med. 2024;184(1):18-27. doi:10.1001/jamainternmed.2023.0699

    2. Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: Systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014;348(April):1-18. doi:10.1136/bmj.g2545

    Summarized by Jorge Chalit, OMSII | Edited by Meg Joyce & Jorge Chalit


    Previous 1 11 12 13 14 15 119 Next

    Related Podcasts

    Fresh Air

    1

    Fresh Air Arts
    Twenty Thousand Hertz

    2

    Twenty Thousand Hertz Arts
    The Black Tapes

    3

    The Black Tapes Arts
    Snap Judgment

    4

    Snap Judgment Arts
    Here’s The Thing with Alec Baldwin

    5

    Here’s The Thing with Alec Baldwin Arts
    The NoSleep Podcast – Creative Reason Media Inc.

    6

    The NoSleep Podcast – Creative Reason Media Inc. Arts
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights